NASDAQ:KIDS
Orthopediatrics Corp.
Orthopediatrics Corp.'s revenue grew 15.4% in fiscal 2025 to $236.3M while operating margin rose to −16.6%. Free cash flow was −$16.0M, −6.8% of revenue, and the diluted share count rose 1.7%.Summary generated from Orthopediatrics Corp.'s SEC filings. Latest annual report filed Mar 4, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$236.3M
Revenue growth+15.4%
Revenue, 5-yr CAGR+27.2%
Gross margin73.1%
Operating margin−16.6%
Net margin−16.8%
ROIC−7.5%
Return on equity−11.3%
Debt / equity0.31
Free cash flow−$16.0M
FCF margin−6.8%
Share count change+1.7%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 98 | 122 | 149 | 205 | 236 |
| Operating income | −18 | −25 | −27 | −35 | −39 |
| Net income | −16 | 1 | −21 | −38 | −40 |
| Free cash flow | −21 | −32 | −44 | −41 | −16 |
Recent filings
- 4Insider transaction report
Sep 11, 2026 - 4Insider transaction report
Sep 11, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KRegulation FD disclosure
Aug 4, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KResults of a shareholder vote
Jun 4, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 1, 2026 - 8-KRegulation FD disclosure
Apr 30, 2026